242 related articles for article (PubMed ID: 29357838)
1. AZGP1 inhibits soft tissue sarcoma cells invasion and migration.
Liu J; Han H; Fan Z; El Beaino M; Fang Z; Li S; Ji J
BMC Cancer; 2018 Jan; 18(1):89. PubMed ID: 29357838
[TBL] [Abstract][Full Text] [Related]
2. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
Albertus DL; Seder CW; Chen G; Wang X; Hartojo W; Lin L; Silvers A; Thomas DG; Giordano TJ; Chang AC; Orringer MB; Bigbee WL; Chinnaiyan AM; Beer DG
J Thorac Oncol; 2008 Nov; 3(11):1236-44. PubMed ID: 18978557
[TBL] [Abstract][Full Text] [Related]
3. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
4. miR-429 inhibits metastasis by targeting KIAA0101 in Soft Tissue Sarcoma.
Samantarrai D; Mallick B
Exp Cell Res; 2017 Aug; 357(1):33-39. PubMed ID: 28432002
[TBL] [Abstract][Full Text] [Related]
5. AZGP1 deficiency promotes angiogenesis in prostate cancer.
Wen RM; Qiu Z; Marti GEW; Peterson EE; Marques FJG; Bermudez A; Wei Y; Nolley R; Lam N; Polasko AL; Chiu CL; Zhang D; Cho S; Karageorgos GM; McDonough E; Chadwick C; Ginty F; Jung KJ; Machiraju R; Mallick P; Crowley L; Pollack JR; Zhao H; Pitteri SJ; Brooks JD
J Transl Med; 2024 Apr; 22(1):383. PubMed ID: 38659028
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma.
Sachdeva M; Whitley MJ; Mito JK; Ma Y; Lev DC; Cardona DM; Kirsch DG
Dis Model Mech; 2015 Aug; 8(8):867-75. PubMed ID: 26044957
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma.
Tian H; Ge C; Zhao F; Zhu M; Zhang L; Huo Q; Li H; Chen T; Xie H; Cui Y; Yao M; Li J
Carcinogenesis; 2017 Feb; 38(2):207-217. PubMed ID: 27993894
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancer.
Huang CY; Zhao JJ; Lv L; Chen YB; Li YF; Jiang SS; Wang W; Pan K; Zheng Y; Zhao BW; Wang DD; Chen YM; Yang L; Zhou ZW; Xia JC
PLoS One; 2013; 8(7):e69155. PubMed ID: 23935945
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
[TBL] [Abstract][Full Text] [Related]
10. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
11. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.
Guo Y; Xie J; Rubin E; Tang YX; Lin F; Zi X; Hoang BH
Cancer Res; 2008 May; 68(9):3350-60. PubMed ID: 18451162
[TBL] [Abstract][Full Text] [Related]
12. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
13. Soft tissue sarcomas of the hand.
Rosenberg AE; Schiller AL
Hand Clin; 1987 May; 3(2):247-61. PubMed ID: 3034928
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance.
Momose T; Yoshimura Y; Harumiya S; Isobe K; Kito M; Fukushima M; Kato H; Nakayama J
Hum Pathol; 2016 Apr; 50():15-23. PubMed ID: 26997434
[TBL] [Abstract][Full Text] [Related]
15. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells.
Thway K; Robertson D; Jones RL; Selfe J; Shipley J; Fisher C; Isacke CM
Br J Cancer; 2016 Aug; 115(4):473-9. PubMed ID: 27434038
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD133 in synovial sarcoma.
Terry J; Nielsen T
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):159-65. PubMed ID: 19752721
[TBL] [Abstract][Full Text] [Related]
17. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
18. Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas.
de Souza RR; Oliveira ID; del Giúdice Paniago M; Yaoita FH; Caran EM; Macedo CR; Petrilli AS; Abib Sde C; de Seixas Alves MT; de Toledo SR
Growth Horm IGF Res; 2014 Aug; 24(4):130-6. PubMed ID: 24846856
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
Das B; Jain N; Mallick B
Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
